199 related articles for article (PubMed ID: 31210301)
1. LncRNA NR027113 promotes malignant progression of gastric carcinoma via EMT signaling pathway.
Chen QF; Hu CF; Sun K; Lang YP
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4746-4755. PubMed ID: 31210301
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
Dong Y; Wang ZG; Chi TS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
5. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis.
Liu XJ; Li SL; Li JS; Lu H; Yin LL; Zheng WF; Wang WC
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2624-2630. PubMed ID: 29771411
[TBL] [Abstract][Full Text] [Related]
7. JMJD3 enhances invasiveness and migratory capacity of non-small cell lung cancer cell via activating EMT signaling pathway.
Zhang Y; Hua PY; Jin CY; Li JD; Zhang GX; Wang B
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4784-4792. PubMed ID: 31210309
[TBL] [Abstract][Full Text] [Related]
8. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
9. LncRNA CHRF promotes cell invasion and migration via EMT in gastric cancer.
Gong J; Wang Y; Shu C
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1168-1176. PubMed ID: 32096147
[TBL] [Abstract][Full Text] [Related]
10. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA SGO1-AS1 inactivates TGFβ signaling by facilitating TGFB1/2 mRNA decay and inhibits gastric carcinoma metastasis.
Huang D; Zhang K; Zheng W; Zhang R; Chen J; Du N; Xia Y; Long Y; Gu Y; Xu J; Deng M
J Exp Clin Cancer Res; 2021 Oct; 40(1):342. PubMed ID: 34706749
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
Dong YZ; Meng XM; Li GS
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.
Ren P; Zhang H; Chang L; Hong XD; Xing L
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3686-3693. PubMed ID: 32329844
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.
Liu J; Wang Z; Yin Y; Li N; Ye NY; Bao B; Gu HC
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3733-3741. PubMed ID: 31114999
[TBL] [Abstract][Full Text] [Related]
16. LINC01857 promotes the development of gastric cancer by regulating microRNA-200b.
Chen GR; Sun W; Zheng K; Zhu W
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3648-3656. PubMed ID: 32329840
[TBL] [Abstract][Full Text] [Related]
17. LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer.
Zhang X; Wu J
Pathol Res Pract; 2021 Aug; 224():153492. PubMed ID: 34091388
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
19. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
Pan L; Liang W; Fu M; Huang ZH; Li X; Zhang W; Zhang P; Qian H; Jiang PC; Xu WR; Zhang X
J Cancer Res Clin Oncol; 2017 Jun; 143(6):991-1004. PubMed ID: 28285404
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
